Faster global financial news!
AiTEM, the AI formulation innovation platform developed by AiTEM Therapeutics, has completed its localized deployment at Hengrui Medicine and signed a strategic cooperation agreement with Zhejiang Hisun Pharmaceutical.
AiTEM, AIT Therapeutics' AI-powered formulation innovation platform, completed its on-premise deployment at Hengrui Pharmaceuticals on August 3rd, to be used for the development of formulations for poorly soluble drugs. Furthermore, after the reporting period, the company also signed a strategic cooperation agreement with Zhejiang Hisun Pharmaceutical Co., Ltd., further expanding its AI platform's on-premise deployment collaborations with pharmaceutical companies.
Source：华尔街见闻 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Genscript Biotech's OpenCGT project has reached delivery technology cooperation agreements with multiple companies, with potential total transaction value exceeding 6 billion yuan.
|
Next: Elon Musk's SpaceX plans to launch millions of satellites to build an orbital data center to support AI, but faces physical and financial challenges.
24H Trending
-
1
BlackRock Bitcoin ETF once reached a $100 billion milestone: the fastest ever, current AUM approximately $98.5 billion, annual revenue target $500 million
-
2
Will SOL Coin Collapse? Can Solana Become the Next Ethereum?
-
3
US Treasury Secretary Bessent Reportedly Prepares Measures to Curb Rising Bond Yields
-
4
Thailand's SEC opens consultations on Bitcoin and Ether ETF rules, including foreign custodian standards
-
5
KingData Platform Features and Analysis: One-Stop Blockchain Data Service
-
6
BitDATA Exchange Token BDT: Multi-Entity and Token Analysis, and Scam Alert
-
7
Analysis indicates that Walmart (WMT) saw a 5.1% year-over-year increase in Q2 revenue and a 2.6% rise in U.S. comparable store sales. However, given its P/E ratio of 38x and a dividend yield below 1%, investors are advised to hold off on buying for now.
-
8
Analog Devices (ADI) Q3 Revenue Soared 40% YoY, Net Income Doubled to $1.34 Billion; Q4 Revenue Guidance Implies Another 40% Growth
-
9
BCUG Coin Analysis: The Current State of Blockchain Cuties Universe Governance Token and Market Liquidity
-
10
Mexico Bonds Trade Like Junk After $130 Billion Bailout of Pemex
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
